The Rivkin Center’s Education Program The Rivkin Center’s education program provides free health education workshops. Instructors educate women about their breast and ovarian health and cancer risks. Say hello to Sarena Perez, one of our instructors and an ovarian cancer
The Rivkin Center’s Education Program The Rivkin Center’s education program provides free health education workshops. Facilitators are cancer survivors who share their story in an effort to educate women about their breast and ovarian health and cancer risks. Say hello
The Journal of Gynecological Cancer recently published the meeting report for the 12th Ovarian Cancer Research Symposium. The symposium was organized by the Rivkin Center in partnership with the American Association for Cancer Research (AACR) at the University of Washington
More than 2,000 participants joined us at the SummeRun & Walk for Ovarian Cancer on Sunday, July 14th — helping raise awareness and funds for critical ovarian cancer research and education. We are so grateful for the support of the
As the annual Swedish SummeRun & Walk for Ovarian Cancer approaches, we wanted to share some fun and creative ways participants have been raising money for their SummeRun teams. Host a Silent Auction Kevin Westrick and his daughter, Whitney, started Rockin’ for Rosie
Seattle, WA: The Rivkin Center, a Seattle-based 501(c)(3), announced that they have awarded $1.455 million in ovarian cancer research grants to sixteen scientists across the globe. The amount funded was nearly a 20% increase over last year. The Rivkin Center’s
The Rivkin Center’s Education Program The Rivkin Center’s education program provides free health education workshops. Instructors educate women about their breast and ovarian health and cancer risks. Say hello to Kristin Anderson, one of our instructors. ABOUT KRISTIN Where are
The Rivkin Center’s education program provides free health education workshops. Rivkin EDU campus ambassadors are the feet-on-the-ground Rivkin Center representatives at universities across the west coast, helping set up workshops, identify opportunities to reach more students, and so much more.
After more than twenty years, we’re excited to unveil a new look and logo for the Rivkin Center. We believe the new brand reflects our aspiration to make a bigger impact for more women now and in the future.
The Federal Drug Administration (FDA) made an exciting announcement this week with the first approval for PARP inhibitors to be used for patients following their initial diagnosis and treatment to reduce the risk of recurrence. The FDA approved the use
Talking to your family and identifying cancer in your family tree can be a good indicator of your health risks. Download our Family Tree Worksheet here. Be sure to include yourself, children, parents, siblings, aunts, uncles, and grandparents.
Ready to take action? Knowledge is power. Take this short quiz to be proactive about your health.
Our bodies are made of many tiny building blocks called cells. Our cells contain a copy of our genome – all of the DNA genetic code we inherited from our parents. Our genome is organized into 46 chromosomes, 23 inherited from mom and 23 from dad. Each chromosome has hundreds or thousands of genes. Each gene has the instructions to make a protein that may control the structure or function of cells, can determine many things including how tall we are or the color of our eyes. Genes also contain instructions for many things inside of us that we cannot see, such as how our bones are formed or how our heart works. Each gene is made up of molecules called nucleic acids (A, T, C, and G). The specific sequence of the nucleic acids holds the instructions that control all the components and their functions in cells.
If the DNA sequence is changed, like a spelling mistake, the instructions may not make sense. The technical term for this change is “mutation,” meaning there is a change to the usual genetic code that may change the instructions stored in the gene. A mutation in a gene that repairs DNA damage or controls cell growth can increase the risk of developing cancer.
Ovarian and breast cancer can be either sporadic or hereditary. Sporadic cancers make up the vast majority (85-90%) of ovarian and breast cancers and are not associated with family history of either cancer or inherited cancer-associated mutations. Sporadic cancers arise from genetic mutations acquired in some cells of the body by events part of normal metabolism and environmental factors. This type of cancer can happen to anyone. Most acquired gene mutations are not shared among relatives or passed on to children.
Hereditary (also known as inherited, or familial) cancers are those that occur due to genetic mutations that are inherited from mom or dad. Other blood relatives may also share these same gene mutations. Parents give one copy of each gene to their children. If a parent has a genetic mutation in a gene, each of their children have a 50% chance of inheriting that mutation. Therefore, even in families with hereditary cancer, not all family members inherit the mutation that is causing cancer, and their risk of cancer is similar to the average person in the general population. Individuals who are suspected to have a family history with high incidence of ovarian, breast, and other cancers may be offered genetic testing to try to find the specific genetic mutation that may put them at risk. Importantly, individuals who do not have a known genetic mutation but have high incidence of ovarian, breast, or other cancers in their families are still considered at higher risk for developing those cancers.
Hereditary cancers often occur at an earlier age than the sporadic form of the same cancer, so experts often recommend starting cancer screening at a younger age for individuals at high risk for hereditary cancer. Hereditary cancers can also be more aggressive than the sporadic form of the same cancer. Individuals who have inherited a gene mutation may be at a higher risk for more than one type of cancer.
The genes that are most commonly involved in hereditary breast and ovarian cancer (HBOC) are BRCA1 and BRCA2. These genes are named for their link to breast (BR) cancer (CA), but they are also linked to ovarian cancer risk as well as other cancers. Both women and men can inherit mutations in these HBOC genes. BRCA1 and BRCA2 are tumor suppressor genes that have a usual role in our body of providing instructions on repairing DNA damage and preventing cancer. When a family has an inherited mutation in BRCA1 or BRCA2, this leads to an increase in cancer risk. Not every man or woman who has inherited a mutation in the BRCA1 or BRCA2 gene will develop cancer, but people who have a mutation do have a significanlty increased chance of developing cancer, particularly cancer of the breasts or ovaries.
While breast and ovarian cancers are the most common cancers diagnosed in people with BRCA1 and BRCA2 mutations, the risk of some other cancers is also increased. Men with BRCA1 and BRCA2 mutations have a higher risk of early-onset prostate cancer than men without mutations in either gene. Other cancers seen at increased rates, particularly in individuals with BRCA2 mutations, include pancreatic cancer and melanoma. Researchers are continuing to find new genes that are involved in hereditary breast and/or ovarian cancer so it is important to follow up with a genetic counselor on a regular basis if hereditary breast and ovarian cancer is likely in your family.
Talk to your family about your health history and take the Assess Your Risk quiz here
